Show simple item record

AuthorSteinhauser, Maximilian Felixdc.contributor.author
Date of accession2016-03-15T10:42:46Zdc.date.accessioned
Available in OPARU since2016-03-15T10:42:46Zdc.date.available
Year of creation2014dc.date.created
AbstractRecently, new approaches like kinase inhibitors and monoclonal antibodies and immunotherapy showed promising results in lung cancer therapy. Vaccination with TAAs, such as MAGE-A3 and hTERT are beeing tested in phase III studies. Therefore it is important to identify new immunogenic targets for immunotherapy. In this study, t-cell mediated specific immune response against 11 peptide epitopes have been tested in patients with advanced NSCLC (n=12) and SCLC (n=2), who haven been selected for HLA-A2 expression from 35 Patients. Therefore mixed lymphocyte/peptide culture and ELISpot assays for interferon gamma and granzyme B were performed. Peptides derived from TAAs RHAMM, PRAME, WT-1, hTERT, Survivin, MAGE A3, G250, HER2 and aurora kinases A and B were tested. 13 of 14 patients showed cellular immune response against at least 1 peptide. Every peptide was able to induce positive reactions in at least 3 patients in one ELISpot assay. G250 G2 and PRAME P3 seem to be interesting targets for immunotherapies, as they induced t-cellular mediated immune response 67 % and 64 % of patients. Both TAAs are expressed by lung cancer in high frequency. This work showed, that patients with advanced lung cancer are able to generate specific t-cell mediated immune responses against varoius peptides epitopes derived from tumor associated antigens. Therefore these peptides are potential targets for immunotherapies against lung cancer.dc.description.abstract
Languagededc.language.iso
PublisherUniversität Ulmdc.publisher
LicenseStandarddc.rights
Link to license texthttps://oparu.uni-ulm.de/xmlui/license_v3dc.rights.uri
Dewey Decimal GroupDDC 610 / Medicine & healthdc.subject.ddc
MeSHBronchial neoplasmsdc.subject.mesh
MeSHT-lymphocytesdc.subject.mesh
TitleNachweis spezifischer T-Zell-vermittelter Immunantworten gegen Tumor assoziierte Antigene bei Lungenkrebsdc.title
Resource typeDissertationdc.type
DOIhttp://dx.doi.org/10.18725/OPARU-3725dc.identifier.doi
PPN843563966dc.identifier.ppn
URNhttp://nbn-resolving.de/urn:nbn:de:bsz:289-vts-97970dc.identifier.urn
GNDBronchialkrebsdc.subject.gnd
GNDImmuntherapiedc.subject.gnd
GNDT-Lymphozytdc.subject.gnd
GNDTumorantigendc.subject.gnd
FacultyMedizinische Fakultätuulm.affiliationGeneral
Date of activation2015-11-25T16:45:26Zuulm.freischaltungVTS
Peer reviewneinuulm.peerReview
Shelfmark print versionW: W-H 14.473uulm.shelfmark
DCMI TypeTextuulm.typeDCMI
VTS-ID9797uulm.vtsID
CategoryPublikationenuulm.category


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record